Rajeev Raghuvanshi, Drug Controller General of India, highlighted India's growing contribution to global healthcare, stating that the country is supplying drugs, vaccines, and medical devices to over 200 nations. He noted that 11 countries have already recognized Indian pharmacopoeia standards. Furthermore, India is approving an average of 100 global clinical trials annually over the past few years. The National Regulatory Authority (NRA) is also reviewing and approving advanced medical technologies such as CAR T cell therapy, mRNA vaccines, and software as medical devices, demonstrating India's evolving expertise in healthcare innovation.
#watch | Drug Controller General of India, Rajeev Raghuvanshi says "India is supplying drugs, vaccines and medical devices to more than 200 countries across the world...11 countries have already recognised Indian pharmacopoeia as their standards. Now we are approving an average… pic.twitter.com/uUfH8ux8p8
— ANI (@ANI) October 14, 2024